Fig 1: ScRNA sequencing and TCR repertoire analysis reveals clonal expansion in the CD8+ effector memory T-cell compartment. (A–H) Murine gastric AP organoids (Apcmin/+; Trp53−/−) were transduced with either an ErbB2 overexpression or control vector and transplanted subcutaneously into wild-type C57BL/6 mice. Six tumors per condition were harvested 7 weeks post-transplantation, and tumor-infiltrating T-cells were FACS-sorted and processed for scRNA sequencing. Uniform manifold approximation and projection (UMAP) of cells from both APctrl and APE conditions, colored by Seurat clusters, is shown in (A); clusters significantly upregulated in APE tumors are annotated. A dot plot showing the log₂ fold change in cluster abundance between APctrl and APE across Seurat clusters is shown in (B). Each dot represents a Seurat cluster; colored dots indicate statistically significant changes, while gray dots are non-significant. Background color indicates enrichment in APctrl (blue) or APE (red). A heatmap showing the top 10 marker genes for clusters significantly enriched in either APctrl or APE is shown in (C), and a UMAP projection of cells from both conditions annotated for T cell states using the ProjecTIL framework is shown in (D). The bar plot in (E) indicates the top 18 clonally expanded T cell clones among ProjecTIL-annotated T cells in both conditions. The UMAP projection in (F) highlights cells belonging to the same top clones as shown in (E). UMAP feature plots in (G, H) show normalized expression levels of the indicated selected marker genes.
Fig 2: ErbB2 overexpression induces micronucleation and a type I IFN response. (A, B) Representative DAPI-stained images (scale bar: 20 µm) of two-dimensional (2D) grown wild-type organoid cells transduced with an ErbB2 overexpression or control vector are shown alongside the quantification of micronuclei in 3000 cells per condition; five independent experiments are shown in B. (C–E) Representative images of immunostained 2D-seeded ErbB2-overexpressing gastric organoid cells are shown in C (scale bar: 20 µm), alongside the quantification of the indicated micronuclei populations in (D, E). Staining was performed using antibodies against Lamin B1 (red) and γH2AX (green), and counterstained with DAPI. White arrows in (C) point to micronuclei. (F, G) Representative images of immunostained 2D-seeded ErbB2-overexpressing gastric organoid cells are shown in F (scale bar: 20 µm), alongside the quantification of cGAS+ micronuclei in (G). Cells were stained with antibodies against Lamin B1 (green), γH2AX (yellow), and cGAS (red). White arrows in F point to a micronucleus. All available micronuclei (100->400 per condition) were analyzed. Data in (D, E) are from five, data in G from three independent experiments. Statistical analysis in (B, D, E, G) was done using Wilcoxon matched-pairs signed rank test. (H) R eal-time quantitative PCR (qRT-PCR) analysis of Isg15 and Ifnb expression in tumors derived from AP organoids (Apcmin/+; Trp53−/−) transduced with empty vector control (APctrl) and ErbB2 overexpression vector (APE) after 7 weeks of subcutaneous growth in wild-type mice. Data are normalized to GAPDH. Each dot represents one tumor. (I) Tumor weight (left) and tumor volume (right) of subcutaneous APE tumors grown in wild-type or Ifnar–/– mice. Each dot represents one tumor. (J) Quantification of CD4+ (left) and CD8+ (right) T cell infiltration per gram of tumor tissue, in wild-type and Ifnar–/– mice. Statistical comparisons in H, I, and J were performed using the non-parametric Mann-Whitney U test. n.s. not significant. (K) Engraftment rate of orthotopically transplanted APE organoids in wild-type and Ifnar–/– mice. The number of injections and mice is indicated. (L–N) Tumor weights (L), CD4+ (M), and CD8+ (N) T cell infiltration per gram of tumor tissue, in wild-type mice transplanted with either AP control or APE organoids (expressing rat ErbB2) transduced with either control shRNA, or STING-specific or IFNAR-specific shRNA. Statistical comparisons were performed using the Kruskal-Wallis test with Dunn’s multiple comparisons correction. *p<0.05; **p<0.01; ***p<0.001; n.s. not significant.
Fig 3: Efficacy of anti-PD1/anti-ErbB2 combination therapy in organoid-derived tumors. (A–D) PD1 expression by CD4+ and CD8+ T-cells as determined by flow cytometry. Counts per g of tissue of the indicated populations are shown for wildtype organoids overexpressing ErbB2 or not in (A) and for AP organoids (Apcmin/+; Trp53−/−) overexpressing ErbB2 or not in (B), alongside representative histograms in (C, D). Each symbol denotes one organoid-derived tumor. Statistical comparisons were performed using the non-parametric Mann-Whitney U test. *p<0.05; n.s., not significant. (E–H) Wildtype mice were injected subcutaneously with APctrl or APE tumors and treated with biweekly doses of isotype or anti-PD1 treatment for the last 3.5 weeks of tumor growth. Tumor weights and volumes are shown in (E, F). Representative pan-cytokeratin-stained tumor sections are shown in G (scale bars: 1000 µm) alongside the flow cytometric quantification of intratumoral CD4+ and CD8+ T-cells in H. (I, J) Wild-type mice were injected subcutaneously with APctrl or APE tumors and treated with biweekly doses of anti-PD1, anti-ErbB2, or isotype control antibody in the indicated combinations for the last 3.5 weeks of tumor growth. Tumor weights and volumes are shown in (I, J), alongside the flow cytometry quantification of CD4+ and CD8+ T-cell infiltration in (K, L). Boxes in (A, B, E, F, H-J) represent medians; bars represent 95% CIs. Each symbol denotes one organoid-derived tumor. Statistical comparisons in (E–J) were performed using the Kruskal-Wallis test with Dunn’s multiple comparisons correction. *p<0.05; **p<0.01; n.s. not significant.
Fig 4: Tumors derived from ErbB2-overexpressing organoids are infiltrated by large numbers of CD4+ and CD8+ T-cells. (A–E) Murine gastric wild-type organoids were lentivirally transduced with either an ErbB2 overexpression (ErbB2 OE) vector or an empty control (Ctrl) vector and transplanted subcutaneously into wild-type C57BL/6 mice. Tumors were harvested 7 weeks post-transplantation and processed for histological analysis and spectral flow cytometry. Engraftment rates and tumor weights of two pooled studies are shown in (A, B). The number of injections (n) and mice are indicated in (A). Representative low and high magnification H&E images are shown in (C). Scale bars: 1000 µm (left panels), 100 µm (right panels). Condition-specific pairwise controlled manifold approximation projections (PaCMAPs) of tumor-infiltrating leukocytes are shown in (D), alongside the frequencies among all CD45+ leukocytes, and absolute numbers per gram of tumor, of CD4+ FoxP3− T-cells in (E). Note that some control tumors had to be pooled for flow cytometry because of low yield. Two pooled studies are shown in (A–E). (F–M) Murine gastric AP organoids (Apcmin/+; Trp53−/−) were transduced with either an ErbB2 overexpression or control vector and transplanted subcutaneously into wild-type C57BL/6 mice. Tumors were harvested 7 weeks post-transplantation and processed for spectral flow cytometry or for histological analysis. Engraftment rates and tumor weights are shown in (F, G). The number of injections and mice used is indicated in (F). Condition-specific PaCMAPs are shown in (H), alongside the frequencies among all CD45+ leukocytes, and absolute numbers per gram of tumor, of CD4+ FoxP3− T-cells and CD8+ T-cells in (I, J). Representative pan-cytokeratin (panCK) and CD3 immunohistochemical staining of tumor tissues is shown in (K) alongside the quantification in (L, M). Scale bars: 2.5 mm (low magnification), 500 µm (intermediate magnification), 100 µm (high magnification). (N–Q) Murine gastric wild-type (N–P) or AP (Q) organoids were lentivirally transduced with either an ErbB2 overexpression or control vector and orthotopically transplanted into wild-type C57BL/6 mice. Tumors were harvested 7 weeks post-transplantation and subjected to spectral flow cytometry. Engraftment rates are shown in (N, Q). Condition-specific PaCMAPs are shown in (O) alongside the frequencies of CD4+ FoxP3− T-cells and CD8+ T-cells in (P). Boxes represent medians; bars represent 95% CIs. Each symbol denotes one organoid-derived tumor. Statistical comparisons were performed using the non-parametric Mann-Whitney U test. *p<0.05; **p<0.01; ****p<0.0001; n.s. not significant.
Fig 5: ErbB2 is localized at the cell surface and induces the expression of innate immune response genes. (A) Overexpression efficiency of Erbb2 as determined by real-time quantitative PCR (qRT-PCR). Expression levels in cells transduced with empty vector (averaged across four experiments) were set to 1. Boxes represent medians; bars represent 95% CIs. Each symbol represents an independent organoid culture. Statistical comparisons were performed using the non-parametric Mann-Whitney U test. *p<0.05. (B) Immunofluorescence staining of 2D-seeded control and ErbB2-overexpressing murine gastric organoid cells. Staining was performed using antibodies against ErbB2 (magenta), Lamin B1 (cyan), E-cadherin (green), and Tubulin (yellow). Nuclei were counterstained with DAPI (blue). Scale bar: 50 µm. (C) Heatmap showing the top 50 genes upregulated in ErbB2-overexpressing vs control organoid cells (n=3 independent cultures per group). Data are from bulk RNA sequencing and presented as log₂-normalized expression values. (D) Volcano plot displaying differentially expressed genes from bulk RNA-seq. Red and blue dots indicate significantly upregulated and downregulated genes, respectively (cut-off: log₂ fold change >1, adjusted p<0.05). Select upregulated genes are labeled. (E) Enriched gene ontology terms among upregulated genes, highlighting pathways associated with cell adhesion, migration, and immune response. Node size indicates the number of genes per term; red dots represent representative genes in each pathway.
Supplier Page from Sino Biological, Inc. for Mouse HER2/ERBB2 Gene ORF cDNA clone expression plasmid